Pancreatic Neoplasms: all 3,311 studies
Page 26 of 34. Open to participants first (911), then studies with results posted, then the rest; newest registration first within each.
- CTC Pancreatic AdenocarcinomaCompletedNCT02335151Phase 4
- Acupuncture for Pain Control in Patients With Inoperable Pancreatic CancerTerminatedNCT02333409Not applicable
- Cancer Development In Organ Transplant RecipientsCompletedNCT02333279
- Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal CancerCompletedNCT02333188Phase 1
- Efficacy and Safety of Radiofrequency Ablation in Pancreatic Neuroendocrine and Cystic TumorCompletedNCT02330497Not applicable
- Prospective Multi-center, Single Blinded, Randomized, Controlled Trial of EUS-FNB and EUS-FNA on Solid Occupying LesionStatus unknownNCT02327065Not applicable
- Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the PancreasStatus unknownNCT02311439Phase 2/3
- Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the PancreasWithdrawnNCT02310971Phase 2
- Pancreatic Cancer Screening of High-Risk Individuals in ArkansasWithdrawnNCT02309632Not applicable
- Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast CancerCompletedNCT02309177Phase 1
- SBRT Pre-operatively for Pancreatic CancerCompletedNCT02308722Phase 1
- Palliative Care in Improving Quality of Life in Patients With Newly Diagnosed Pancreatic CancerCompletedNCT02307539Not applicable
- Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard TherapyCompletedNCT02307500Phase 2
- Follow-up Study of Complications of Acute PancreatitisStatus unknownNCT02305914
- Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic CancerStatus unknownNCT02305186Phase 1/2
- The Pre-operative Pathway in Pancreatic Head Malignancy-assessment of the Diagnostic Accuracy of Staging CT ScanCompletedNCT02296736
- Preoperative Rehabilitation During Neoadjuvant Therapy for Pancreatic CancerCompletedNCT02295956Early Phase 1
- Efficacy and Feasibility of Combining FOLFIRINOX and Stereotactic Radiotherapy for Patients With Irresectable Locally Advanced Pancreatic Cancer.CompletedNCT02292745Not applicable
- Evaluation of 4D-contrast Enhanced PET-CT in Tumour Volume DefinitionStatus unknownNCT02285660Not applicable
- Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic CancerCompletedNCT02283372Phase 1
- A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051bCompletedNCT02279433Phase 1
- Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic CancerStatus unknownNCT02278458Phase 1
- Characterizing the Pancreatic Cancer Proteome From Pancreatic JuiceCompletedNCT02277834
- A Study of Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic CancerCompletedNCT02272738Phase 1
- A Prospective, Multi-center Trial for Reinforced Staple During Distal PancreatectomyCompletedNCT02270554Phase 2
- Robotic vs. Laparoscopic Distal Pancreatectomy for Pancreatic CancerWithdrawnNCT02269683Not applicable
- Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic HyperbilirubinemiaTerminatedNCT02267707Phase 1
- Longitudinal Pancreatic Cancer StudyCompletedNCT02250638
- A Clinical Trial With a New Needle Device Comparing Two Needles for EUS_FNA of Solid Lesions.Status unknownNCT02246322Not applicable
- Study of Gemcitabine and Abraxane for Pancreas CancerTerminatedNCT02242409Phase 2
- Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase IICompletedNCT02230176Phase 2
- Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic CancerCompletedNCT02227940Phase 1
- Randomized, Controlled Trial of Endoscopic Ultrasound-Guided Bilateral Celiac Plexus Neurolysis vs Celiac Ganglia Neurolysis to Control Pain in Inoperable Pancreatic Cancer Patients With Inadequate Pain Control by Pain KillerStatus unknownNCT02220062Not applicable
- Dose-finding Study of BI 2536 Administered in Combination With Gemcitabine in Patients With Locally Advanced or Metastatic Pancreatic CancerTerminatedNCT02215044Phase 1
- Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC).CompletedNCT02210364Phase 1
- EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic CancerStatus unknownNCT02209415Not applicable
- Pancreatic Cancer Early Detection ProgramCompletedNCT02206360
- Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic CarcinomaCompletedNCT02195180Phase 2
- Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic CancerCompletedNCT02191761Phase 1
- Comparison Between Base and Cover Slide From Endoscopic Ultrasound Guided Fine Needle Aspiration for Pancreatic CancerCompletedNCT02190071
- Evaluation of an Adapted Physical Activity Program in Patients With Unresectable Pancreatic CancerActive, not recruitingNCT02184663Not applicable
- Quality of Life After Surgery for Pancreatic CarcinomaCompletedNCT02175992
- Feasibility of Using Ultrasound to Track Respiration MotionCompletedNCT02173353
- APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By SurgeryCompletedNCT02166255Phase 1
- RFA RCT for Pancreatic or Bile Duct CancerTerminatedNCT02166190Not applicable
- Clinical Trial of Pancreatic Cancer in Stockholm.CompletedNCT02162823
- Tolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring RadiationWithdrawnNCT02159248Phase 1
- BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic CancerCompletedNCT02155088Phase 1
- Gemcitabine and Pulse Dose Erlotinib in Second Line Treatment of Advanced Pancreatic CancerCompletedNCT02154737Phase 1
- A Study of LY2157299 in Participants With Pancreatic Cancer That is Advanced or Has Spread to Another Part of the BodyCompletedNCT02154646Phase 1
- Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic CancerCompletedNCT02153450Early Phase 1
- Evaluation of PET-CT Using Somatostatin Agonists Labeled With Gallium68 in Neuroendocrine TumorsCompletedNCT02150408Not applicable
- Effect of Oncothermia on Improvement of Quality of Life in Unresectable Pancreatic Cancer PatientsCompletedNCT02150135Phase 1
- Neoadjuvant FIRINOX for Borderline Resectable Pancreatic Cancer - a Pilot StudyCompletedNCT02148549Phase 1
- A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic CancerCompletedNCT02146313Phase 1
- Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic CancerCompletedNCT02138383Phase 1
- Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Advanced Pancreatic CancerStatus unknownNCT02135822Phase 2
- (PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic CancerTerminatedNCT02132403Phase 1
- Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung CancerCompletedNCT02132325Not applicable
- S-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic CancerCompletedNCT02131493Phase 2
- Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic CancerStatus unknownNCT02124317Phase 2
- Sequential Trial of G17DT for the Treatment of Advanced Pancreatic CancerCompletedNCT02118077Phase 3
- Left Celiac Plexus Resection for Pancreatic Cancer at the Body and TailStatus unknownNCT02117895Phase 3
- EUS vs. MDCT in Pancreatic MalignancyCompletedNCT02115022
- Phase I/II Study to Evaluate Nab-paclitaxel in Substitution of CPT11 or Oxaliplatin in FOLFIRINOX Schedule as First Line Treatment in Metastatic Pancreatic CancerCompletedNCT02109341Phase 1/2
- Study of Sildenafil as a Therapy for Fatigue in Pancreatic CancerWithdrawnNCT02106871Phase 1
- Ph 1B Trial With ADI-PEG 20 Plus Nab-Paclitaxel and Gemcitabine in Subjects With Pancreatic CancerCompletedNCT02101580Phase 1
- An Open, Single-center Study to Determine the Antibody Repsonse to Gastrimmune and Its Safety and Tolerability in Patients With Advanced Pancreatic CarcinomaCompletedNCT02098291Phase 2
- Single Centre Study to Determine the Antibody Response to G17DT in Patients With Advanced Pancreatic Cancer.CompletedNCT02098239Phase 2
- Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic CancerCompletedNCT02092948Phase 1
- RCT: Difference in Diagnostic Yield Between EUSFNA Needles With and Without a Side Port in Pancreatic MassesCompletedNCT02092519Phase 4
- Tumor Registry Pancreatic CancerCompletedNCT02089269
- Electroporation (NanoKnife) as Treatment for Advanced Pancreatic CancerCompletedNCT02079623
- DNA Promoter Hypermethylation as a Blood Based Maker for Pancreatic CancerStatus unknownNCT02079363
- Diagnostic Accuracy of Gallium-68-DOTATATE PET/CT Compared to Indium-111-pentetreotide Scintigraphy (SPECT/CT) for Gastroenteropancreatic Neuroendocrine TumorsTerminatedNCT02078843Phase 1/2
- Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.CompletedNCT02078700Phase 2
- Safety Study of Cancer Stem Cell Vaccine to Treat Pancreatic CancerCompletedNCT02074046Phase 1/2
- Endoscopic Evaluation of Premalignant Lesions in the Biliary Tract and Pancreatic DuctsCompletedNCT02057146Not applicable
- Perceptions of Exceptional Patients in Cancer Care Relating to Their Unusual SurvivalCompletedNCT02055313
- Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic CancerCompletedNCT02050178Phase 1
- Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic CancerWithdrawnNCT02048943Phase 1
- Neoadjuvant Plus Adjuvant or Only Adjuvant Nab- Paclitaxel Plus Gemcitabine for Resectable Pancreatic CancerCompletedNCT02047513Phase 2
- Effects of Dexmedetomidine During IRE Procedures for Solid TumoursCompletedNCT02044224Phase 4
- Abraxane and Gemcitabine Versus Gemcitabine Alone in Locally Advanced Unresectable Pancreatic Cancer.CompletedNCT02043730Phase 2
- Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic CancerCompletedNCT02043288Phase 3
- Radiofrequency Probe for Management of Unresectable Bile Duct and Pancreatic CancerStatus unknownNCT02042859Phase 1
- A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA MutationCompletedNCT02042378Phase 2
- Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer.CompletedNCT02035072Phase 2
- mFOLFIRINOX as First-Line Chemotherapy in Treating Chinese Patients With Metastatic Pancreatic CancerCompletedNCT02028806Phase 2
- Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic CancerStatus unknownNCT02024633Phase 1
- Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2CompletedNCT02024009Phase 1/2
- Nab-paclitaxel Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative ResectionCompletedNCT02023021Phase 2
- A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046.CompletedNCT02021500
- A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard ChemotherapyCompletedNCT02021422Phase 1
- Magnetic Resonance Imaging (MRI) in MotionCompletedNCT02019199
- Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative ResectionCompletedNCT02005419Phase 2
- A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic CancerCompletedNCT02005315Phase 1
- Surgery Plus Celiac Nerve Block for Long-term Pancreatic Cancer Pain ControlCompletedNCT02002806Not applicable
- Diagnosis of Bile Duct StricturesCompletedNCT02000999
- The Role of Early Systematic Best Palliative Care Versus on Request Palliative Care Consultation During Standard Oncologic Treatment for Patients With Advanced Gastric or Pancreatic Cancers: a Randomized, Controlled, Multicenter Trial.CompletedNCT01996540Not applicable